Nucleic Acids Research publishes a study authored by NTNU Professor and APIM Therapeutics's CSO Marit Otterlei and co-workers. The study shows that peptides containing the PCNA interacting motif APIM bind to the β-clamp and inhibit bacterial growth and mutagenesis. These results suggest that APIM-peptides could have clinical applications in combination with other antibiotics and as single agents. A copy of the publication is available here.
